Joseph Leveque
Chief Medical Officer
Healthcare
EMD Serono Inc
Australia
Biography
Joseph Leveque, M.D. is Chief Medical Officer at EMD Serono, Inc. His responsibilities include integrating medical, development and regulatory strategies into programs that accelerate the assimilation and translation of knowledge and pivotal insights into clinical practice. In doing so, Dr. Leveque plays a key role in advancing our commitment to innovation and bringing new therapeutic options to patients in need. Dr. Leveque has more than 20 years of experience across the healthcare provider, finance, bioinformatics and biopharmaceutical industry segments. He has a record for of developing world-class medical teams that advance innovative solutions to solve complex problems. In 2015, Dr. Leveque and his team were recognized by the US Oncology Network with its LEAD (Leadership in Education And Clinical Development) award, which honors life sciences companies for their commitment to the research and clinical education that rapidly and effectively brings innovative medicines to cancer patients. In 2012, Dr. Leveque was recognized by the Multiple Myeloma Research Foundation as one of the top 15 innovators in multiple myeloma over the previous 15 years.
Research Interest
Joseph Leveque, M.D. is Chief Medical Officer at EMD Serono, Inc. His responsibilities include integrating medical, development and regulatory strategies into programs that accelerate the assimilation and translation of knowledge and pivotal insights into clinical practice. In doing so, Dr. Leveque plays a key role in advancing our commitment to innovation and bringing new therapeutic options to patients in need. Dr. Leveque has more than 20 years of experience across the healthcare provider, finance, bioinformatics and biopharmaceutical industry segments. He has a record for of developing world-class medical teams that advance innovative solutions to solve complex problems. In 2015, Dr. Leveque and his team were recognized by the US Oncology Network with its LEAD (Leadership in Education And Clinical Development) award, which honors life sciences companies for their commitment to the research and clinical education that rapidly and effectively brings innovative medicines to cancer patients. In 2012, Dr. Leveque was recognized by the Multiple Myeloma Research Foundation as one of the top 15 innovators in multiple myeloma over the previous 15 years.
